Affordable Diabetes Drug Reduces Long-COVID Risk by 41 Percent: Study

Affordable Diabetes Drug Reduces Long-COVID Risk by 41 Percent: Study
luchschenF/shutterstock
|Updated:
0:00

Is there a way to prevent long COVID? A new study in the United States found that taking metformin, an affordable first-line Type 2 diabetes drug, shortly after diagnosis of COVID-19 can reduce the risk of developing long COVID by about 41 percent.

The study was conducted by researchers from the University of Minnesota, and the paper was published in the international medical journal The Lancet Infectious Diseases in June.
Related Topics